Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing

Diabetic Medicine

Volumn 33, Issue 8, 2016, Pages 1052-1059

  Cuthbertson, D J ^a   Bell, J A ^b   Ng, S Y ^a   Kemp, G J ^a   Kivimaki, M ^b   Hamer, M ^b,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; DYNAPENIA; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE DISEASE; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; SEX RATIO; SMOKING; WAIST CIRCUMFERENCE;

EID: 84978834421     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12991     Document Type: Article

References (31)

1. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547–558.
2. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 55: 889–896.
3. Vetrano DL, Landi F, Volpato S, Corsonello A, Meloni E, Bernabei R et al. Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci 2014; 69: 1154–1161.
4. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci 2008; 63: 829–834.
5. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in Type 2 diabetes. Diabetes Care 2009; 32: S157–S163.
6. Sayer AA, Syddall HE, Dennison EM, Martin HJ, Phillips DI, Cooper C et al. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 2007; 100: 707–713.
7. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PloS One 2010; 5: e10805.
8. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011; 96: 2898–2903.
9. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 1985 2007; 102: 919–925.
10. Visser M, van Venrooij LM, Vulperhorst L, de Vos R, Wisselink W, van Leeuwen PA et al. Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis 2013; 23: 511–518.
11. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci 2000; 904: 437–448.
12. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2013; 56: 270–278.
13. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X–ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc 2013; 61: 974–980.
14. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010; 33: 1652–1654.
15. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995–2004.
16. Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 2009; 89: 1895–1900.
17. UK_Data_Archive. ELSA user guide and documentation. 2008.
18. Hamer M, Stamatakis E. Screen-based sedentary behavior, physical activity, and muscle strength in the English longitudinal study of ageing. PLoS One 2013; 8: e66222.
19. Graig R, Deverill C, Pickering K. Quality control of blood, saliva and urine analytes. In: Spronston K, Mindell J eds. Health Survey for England 2004, Methodology and Documentation. London: The Information Centre, 2006: 34–41.
20. Smith L, Hamer M. Television viewing time and risk of incident diabetes mellitus: the English Longitudinal Study of Ageing. Diabet Med 2014; 31: 1572–1576.
21. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB et al. Relationship of interleukin–6 and tumor necrosis factor–alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57: M326–M332.
22. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin–6 and C–reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000; 55: M709–M715.
23. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006; 61: 1059–1064.
24. Clark BC, Manini TM. Functional consequences of sarcopenia and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care 2010; 13: 271–276.
25. Dunstan DW, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG. Effects of a short-term circuit weight training program on glycaemic control in NIDDM. Diabetes Res Clin Pract 1998; 40: 53–61.
26. Eves ND, Plotnikoff RC. Resistance training and type 2 diabetes: considerations for implementation at the population level. Diabetes Care 2006; 29: 1933–1941.
27. Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006; 55: 1813–1818.
28. Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, de Rekeneire N et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009; 32: 1993–1997.
29. Harrison BC, Leinwand LA. Fighting fat with muscle: bulking up to slim down. Cell Metab 2008; 7: 97–98.
30. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC–1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 2009; 106: 20405–20410.
31. Willey KA, Singh MA. Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights. Diabetes Care 2003; 26: 1580–1588.